|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||168.06 - 169.81|
|52 Week Range||124.84 - 194.40|
|PE Ratio (TTM)||29.60|
|Earnings Date||Apr 30, 2018 - May 4, 2018|
|Forward Dividend & Yield||2.00 (1.18%)|
|1y Target Est||208.00|
The Federal Trade Commission’s approval of the Advocate Health Care and Aurora Health Care hospital merger could be a good sign for CVS Health's purchase of Aetna amid major health industry consolidation.
The most undervalued stocks that Glenview Capital Managment owns as disclosed by the firm's most recent 13F filing. Larry Robbins: The Suggestivist Larry Robbins is a hedge fund manager and CEO of Glenview ...
CVS Health tapped a former Eli Lilly finance chief to run its pharmacy benefit business as the drugstore giant works to complete an acquisition of insurer Aetna.
After being the only one to finish 2016 in the red, the healthcare sector made a comeback in 2017 and finished the year up 21.7%, barely lagging the S&P 500’s (SPX) 21.83% increase. It’s still early in ...
The new information at our fingertips offers hope that we can not only make progress against a litany of diseases, but also begin to reverse our soaring national health bill.
UnitedHealth Group’s (UNH) quarterly dividends will be paid on March 20, 2018. On February 14, 2018, the company announced the authorization of a quarterly dividend payment of $0.75 per share to shareholders of record on March 9, 2018, payable on March 20, 2018. The dividend amount is the same as previous quarters and reflects an increase of ~20% compared to the quarterly dividend payment of $0.15 per share paid in the previous fiscal year.
The CVS Health (CVS)-Aetna deal has surfaced after Amazon, Berkshire Hathaway and JPMorgan Chase revealed their plans to form a joint venture.
Aetna shareholders voted overwhelmingly Tuesday to approve the CVS Health's plan to buy the health insurer for $69 billion. Once the deal is completed, Aetna (AET) shareholders will receive $145 in cash and 0.8378 of a CVS Health (CVS) share for each Aetna share they own. CVS shareholders also voted in favor of the deal at a special meeting Tuesday.
CVS Health Corp. and Aetna Inc. stockholders have voted to approve the pharmacy company’s acquisition of the health insurer.
CVS Health and Aetna shareholders have approved a merger between the two health-care giants, bringing them one step closer to finalizing a deal that could transform the industry.
At today’s special meeting of Aetna shareholders, approximately 97 percent of the votes cast, and over 77 percent of the 326,942,525 shares outstanding and entitled to vote, voted to approve and adopt the agreement and plan of merger dated as of December 3, 2017, as it may be amended from time to time, pursuant to which CVS Health has agreed to acquire Aetna.
WOONSOCKET, R.I., March 13, 2018 /PRNewswire/ -- In a special meeting held today, CVS Health Corporation (CVS) stockholders voted to approve the shares of company stock to be issued in the company's acquisition of Aetna Inc. (AET), one of the nation's leading diversified health care benefits companies. "When this merger is complete, the combined company will be well-positioned to reshape the consumer health care experience, putting people at the center of health care delivery to ensure they have access to high-quality, more affordable care where they are, when they need it," said Larry Merlo, CVS Health president and CEO.